Global Next Generation Sequencing (NGS) Market to Reach $8,599.5 Million by 2020
The Asian market, especially India and China, is expected to witness a boost in demand for NGS products and services and are poised to register maximum growth over the next five-six years, as a result of their economic development, increasing genetic research and development activities, drastically reduced mass scale genetic testing costs, and the growing focus of the global NGS players in this region.
Wembley, United Kingdom, August 07, 2015 --(PR.com)-- Meticulous Research announced the release of new market research report titled, “Global Next Generation Sequencing (NGS) Market Outlook: 2015-2020.” This latest publication from Meticulous Research states that the global next generation sequencing market would reach $8,599.5 million by 2020 at a CAGR of 21.3% over the period of 2015 to 2020. The report analyzes the major drivers, restraints, opportunities, and challenges that have a long and short-term impact on its growth across the globe.
Browse In Depth Report At:
http://www.meticulousresearch.com/research/1028/
Over the years, the next generation sequencing field has witnessed significant growth which has attracted many companies, researchers, investors, and others. The growth of this market is mainly driven by continuous innovation and developments in the market, promotion of NGS by research laboratories and academics, reduced cost of sequencing with the use of NGS, and rising support from various government bodies to promote use of NGS in research and development. As a result, various companies in the pharmaceutical industry have recognized the potential benefits of next generation sequencing as a research and development tool. This is evident from the recent major events such as agreement between Roche and Foundation Medicine to acquire a majority interest in Foundation Medicine for approximately $780 million, and various other agreements and investments from the companies like Genentech, Pfizer, and 10x Genomics. Moreover, an increasing rate of cancer diseases, drastically reduced mass scale genetic testing costs, growing economy, and increasing genetic research and development activities in countries like India, Singapore, and China provide significant opportunities for the players to invest in this market. However, decrease in capital expenditure from academic institutions, high reliability on grants and funds from government, accuracy and standardization concern in diagnostic testing, and legal and ethical issues related to next generation sequencing hinders the growth of this market.
The global NGS market is segmented by products and services, NGS methods, technology, sequencing platforms, applications, end users, and geography. The NGS market by methods is further categorized into genomics, transcriptomics, and epigenomics. The application market is mainly divided into diagnostics, drug discovery, genetic screening, personalized medicine, agriculture and animal research, and others. While by products and services the market is further divided into NGS reagents and accessories, sequencing platforms, data analysis software and tools, sequencing chips, NGS services, and others. Further, various sequencing platforms offered by Illumina, Thermo Fisher Scientific, 454 Roche, and Pacific Biosciences are analyzed under platforms category. The end users market is divided into academic and research institutes, hospitals and healthcare institutions, Biopharma companies, and others.
North America holds the major share in the global NGS market and is expected to dominate this market during the forecast period, with the U.S. contributing a major share, followed by Europe, and Asia-Pacific. On the other hand, the Asian market, especially India and China, is expected to witness a boost in demand for NGS products and services and are poised to register maximum growth over the next five-six years, as a result of their economic development, increasing genetic research and development activities, drastically reduced mass scale genetic testing costs, and the growing focus of the global NGS players in this region.
The key players in the global NGS market are Illumina, Inc., Pacific Biosciences, Roche Holding AG, Thermo Fisher Scientific, Knome, Inc., Perkin Elmer, Inc., Qiagen N.V., Beijing Genomics Institute, Agilent Technologies, Inc., Partek Incorporated, Macrogen, Inc., GenoLogics Life Sciences Software, Inc., and Biomatters, Ltd.
The market research report titled “Global Next Generation Sequencing (NGS) Market Outlook: 2015-2020” contains meticulous & comprehensive analysis of next generation sequencing market in terms of NGS products and services, methods, platforms, technology, application, and geography.
Key questions answered in the report-
- Which are the high growth market segments in terms of NGS product and services, platforms, applications, end-users, methods, technology, regions, and countries?
- What is the historical market for NGS across the globe?
- What are the market forecasts and estimates from the period 2015-2020?
- What are the major drivers, restrains, threats, and opportunities in the global NGS market?
- What are the burning issues of the global NGS market?
- Who are the major players in the global NGS market and what share of the market do they hold?
- Who are the major players in various regions (North America, APAC, Europe) and what share of the market do they hold?
- What are the competitive landscapes and who are the market leaders by sub-region in the global NGS market?
- What are the recent developments in the global NGS market?
- What are the different strategies adopted by the major players in the global NGS market?
- What are the geographical trends and high growth regions?
About Meticulous Research
We are Meticulous. We are one of the leading market research and consulting company focusing on medical devices, biotechnology, healthcare IT, pharmaceuticals, food and beverages, and agriculture domains. We provide solutions to our clients through our market research support, data management services & advanced analytical skills. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation and analysis of data including qualitative and quantitative research with the finest team of analysts.
We focus on client satisfaction by delivering excellent market research solutions which help organizations to adapt, sustain, and grow in the changing business environment.
Contact:
sales@meticulousresearch.com
Visit: http://www.meticulousresearch.com/
Browse In Depth Report At:
http://www.meticulousresearch.com/research/1028/
Over the years, the next generation sequencing field has witnessed significant growth which has attracted many companies, researchers, investors, and others. The growth of this market is mainly driven by continuous innovation and developments in the market, promotion of NGS by research laboratories and academics, reduced cost of sequencing with the use of NGS, and rising support from various government bodies to promote use of NGS in research and development. As a result, various companies in the pharmaceutical industry have recognized the potential benefits of next generation sequencing as a research and development tool. This is evident from the recent major events such as agreement between Roche and Foundation Medicine to acquire a majority interest in Foundation Medicine for approximately $780 million, and various other agreements and investments from the companies like Genentech, Pfizer, and 10x Genomics. Moreover, an increasing rate of cancer diseases, drastically reduced mass scale genetic testing costs, growing economy, and increasing genetic research and development activities in countries like India, Singapore, and China provide significant opportunities for the players to invest in this market. However, decrease in capital expenditure from academic institutions, high reliability on grants and funds from government, accuracy and standardization concern in diagnostic testing, and legal and ethical issues related to next generation sequencing hinders the growth of this market.
The global NGS market is segmented by products and services, NGS methods, technology, sequencing platforms, applications, end users, and geography. The NGS market by methods is further categorized into genomics, transcriptomics, and epigenomics. The application market is mainly divided into diagnostics, drug discovery, genetic screening, personalized medicine, agriculture and animal research, and others. While by products and services the market is further divided into NGS reagents and accessories, sequencing platforms, data analysis software and tools, sequencing chips, NGS services, and others. Further, various sequencing platforms offered by Illumina, Thermo Fisher Scientific, 454 Roche, and Pacific Biosciences are analyzed under platforms category. The end users market is divided into academic and research institutes, hospitals and healthcare institutions, Biopharma companies, and others.
North America holds the major share in the global NGS market and is expected to dominate this market during the forecast period, with the U.S. contributing a major share, followed by Europe, and Asia-Pacific. On the other hand, the Asian market, especially India and China, is expected to witness a boost in demand for NGS products and services and are poised to register maximum growth over the next five-six years, as a result of their economic development, increasing genetic research and development activities, drastically reduced mass scale genetic testing costs, and the growing focus of the global NGS players in this region.
The key players in the global NGS market are Illumina, Inc., Pacific Biosciences, Roche Holding AG, Thermo Fisher Scientific, Knome, Inc., Perkin Elmer, Inc., Qiagen N.V., Beijing Genomics Institute, Agilent Technologies, Inc., Partek Incorporated, Macrogen, Inc., GenoLogics Life Sciences Software, Inc., and Biomatters, Ltd.
The market research report titled “Global Next Generation Sequencing (NGS) Market Outlook: 2015-2020” contains meticulous & comprehensive analysis of next generation sequencing market in terms of NGS products and services, methods, platforms, technology, application, and geography.
Key questions answered in the report-
- Which are the high growth market segments in terms of NGS product and services, platforms, applications, end-users, methods, technology, regions, and countries?
- What is the historical market for NGS across the globe?
- What are the market forecasts and estimates from the period 2015-2020?
- What are the major drivers, restrains, threats, and opportunities in the global NGS market?
- What are the burning issues of the global NGS market?
- Who are the major players in the global NGS market and what share of the market do they hold?
- Who are the major players in various regions (North America, APAC, Europe) and what share of the market do they hold?
- What are the competitive landscapes and who are the market leaders by sub-region in the global NGS market?
- What are the recent developments in the global NGS market?
- What are the different strategies adopted by the major players in the global NGS market?
- What are the geographical trends and high growth regions?
About Meticulous Research
We are Meticulous. We are one of the leading market research and consulting company focusing on medical devices, biotechnology, healthcare IT, pharmaceuticals, food and beverages, and agriculture domains. We provide solutions to our clients through our market research support, data management services & advanced analytical skills. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation and analysis of data including qualitative and quantitative research with the finest team of analysts.
We focus on client satisfaction by delivering excellent market research solutions which help organizations to adapt, sustain, and grow in the changing business environment.
Contact:
sales@meticulousresearch.com
Visit: http://www.meticulousresearch.com/
Contact
Meticulous Research
John Pitt
918055561003
www.meticulousresearch.com/
John Pitt
918055561003
www.meticulousresearch.com/
Contact
Categories